Loading...
XNAS
SBRA
Market cap5.05bUSD
Jul 09, Last price  
19.88USD
1D
-0.75%
1Q
-2.83%
Jan 2017
-18.59%
IPO
-29.58%
Name

Sabra Health Care REIT Inc

Chart & Performance

D1W1MN
XNAS:SBRA chart
P/E
32.22
P/S
6.47
EPS
0.62
Div Yield, %
5.99%
Shrs. gr., 5y
3.36%
Rev. gr., 5y
5.29%
Revenues
775m
+10.15%
8,800,00084,225,000103,170,000134,780,000183,518,000238,864,000260,526,000405,647,000623,409,000668,185,000598,569,000569,545,000624,811,000647,514,000703,235,000774,632,000
Net income
156m
+22.81%
7,378,00012,842,00019,513,00033,715,00046,952,00079,413,00070,276,000158,383,000279,082,00068,996,000138,417,000-113,256,000-77,605,00013,756,000126,712,000155,609,000
CFO
349m
+12.26%
6,600,00044,705,00056,252,00062,099,00085,337,000121,101,000176,739,000133,486,000358,543,000372,475,000354,852,000356,390,000315,733,000300,571,000310,541,000348,613,000
Dividend
Nov 17, 20250.3 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

As of March 31, 2022, Sabra Health Care REIT, Inc. held a diverse investment portfolio. This largely comprised 416 income-generating real estate properties, which included: 279 skilled nursing and transitional care facilities; 59 senior living communities operating under lease agreements; 50 senior housing properties managed by external operators; 13 behavioral health centers; and 15 specialized hospitals and other healthcare sites. In addition to its real estate holdings, Sabra's portfolio also featured: a single asset earmarked for sale; one sales-type lease arrangement; a total of 16 loan receivables, consisting of two mortgage loans, one construction loan, and thirteen other debt instruments; seven preferred equity stakes; and an interest in one unconsolidated joint venture. Collectively, these 416 investment properties offered a capacity of 41,445 beds and residential units, geographically distributed across both the United States and Canada.
IPO date
Nov 06, 2010
Employees
42
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT